DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Retinal Imaging Devices Market (2019-2025)" report has been added to ResearchAndMarkets.com's offering.
The Asia Pacific Retinal Imaging Devices Market is expected to witness market growth of 7.1% CAGR during the forecast period (2019-2025).
Optical coherence tomography (OCT) is equivalent to a histopathological portion of tissue. One can examine individual retinal cell layers and pathological lesions within them. OCT detects a subtle pathology that often goes overlooked during a clinical exam. An OCT device is used on an undilated pupil. Despite the density of cataracts, modern OCT machines can capture images of good quality. The recent addition of OCT angiography allows for dyeless visualization in the macula of retinal vessels.
In the end-use segment, the ambulatory surgery centers (ASCs) sub-segment has been anticipated to grow at the highest growth rate over the forecast period. The growth of the segment is expected to be driven by effective reimbursement policies by Medicare for vitreoretinal surgery in these centers. Hospitals retained the largest market share of retinal imaging products in 2018 due to the high demand for technologically advanced solutions.
Among middle-income countries, retinal disorders have been regarded as the critical causes behind the massive state of blindness across the world. In a recent rapid assessment of avoidable blindness plus diabetic retinopathy (RAAB plus DR) study in Western India, posterior segment disorders (PSD) accounted for nearly 39% of blindness next to cataract (45%). The major retinal diseases of public health significance are retinopathy of prematurity (ROP), diabetic retinopathy (DR), and age-related macular degeneration (ARMD).
Based on Type, the market is segmented into Fundus Camera, Fluorescein Angiography and OCT (Optical Coherence Tomography). Based on End Use, the market is segmented into Hospitals, Ophthalmic Centers, ASCs (Ambulatory Surgery Centers) and Other End Use. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.
Key Topics Covered:
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.3 Market Scope
1.4.1 Asia Pacific Retinal Imaging Devices Market, by Type
1.4.2 Asia Pacific Retinal Imaging Devices Market, by End Use
1.4.3 Asia Pacific Retinal Imaging Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2019-Oct - 2015-Jan) Leading Players
Chapter 4. Asia Pacific Retinal Imaging Devices Market by Type
4.1 Asia Pacific Fundus Camera Market by Country
4.2 Asia Pacific Fluorescein Angiography Market by Country
4.3 Asia Pacific OCT Market by Country
Chapter 5. Asia Pacific Retinal Imaging Devices Market by End-Use
5.1 Asia Pacific Hospitals Market by Country
5.2 Asia Pacific Ophthalmic Centers Market by Country
5.3 Asia Pacific ASCs Market by Country
5.4 Asia Pacific Other End-Use Market by Country
Chapter 6. Asia Pacific Retinal Imaging Devices Market by Country
6.1 China Retinal Imaging Devices Market
6.2 India Retinal Imaging Devices Market
6.3 Japan Retinal Imaging Devices Market
6.4 Australia Retinal Imaging Devices Market
6.5 South Korea Retinal Imaging Devices Market
6.6 Singapore Retinal Imaging Devices Market
6.7 Rest of Asia Pacific Retinal Imaging Devices Market
Chapter 7. Company Profiles
7.1 Topcon Corporation
7.2 Carl Zeiss AG
7.3 Olympus Corporation
7.4 Robert Bosch GmbH (Bosch Healthcare)
7.5 Revenio Group Oyj (CenterVue SpA)
7.6 Nikon Corporation (Optos PLC)
7.7 Optomed PLC
7.8 Epipole Ltd.
7.9 Nidek Co., Ltd.
7.10 Eyenuk, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/p1i5po